The global vitiligo treatment market is growing at a CAGR of 5.5% during the forecast period. One of the major factors that are augmenting the growth of the vitiligo treatment market is the increasing number of clinical trials, growing awareness among populations. Moreover, the growing accessibility for appropriate treatment along with the increasing development of a potential drug and evolvement of a new novel therapy is also estimated to be the other important factor that is contributing significantly towards the growth of the global vitiligo treatment market.
Get Sample Copy of this Report at
https://www.omrglobal.com/request-sample/vitiligo-treatment-market
However, the high cost of treatment and stringent regulation for drug development is some factor constraints that are hindering the growth of the global vitiligo treatment market across the globe. Moreover, undergoing clinical trials by various manufacturers in emerging regions are some of the key factors that are creating opportunities for the market. A new offering in the market is likely to drive the growth of the global vitiligo treatment market. For instance, in May 2020, TWi Biotechnology had announced that the company had received Clinical Trial Application (CTA) approval from Health Canada in order to perform a Phase 1 clinical trial with AC-1101 gel. The AC-1101 is considered a topical JAK inhibitor for the purpose of providing effective treatment to patients suffering from vitiligo.
Impact of COVID-19 Pandemic on Global Vitiligo Treatment Market
The COVID-19 pandemic had impacted various industries in an adverse manner. Additionally, the global vitiligo treatment market is hardly hit by the COVID-19 pandemic since December 2019. The outbreak of COVID-19 in these major economies has disrupted the manufacturing and transportation sector across the globe. This COVID-19 pandemic had also led to disturbance in health clinics, especially in the US.
Segmental Outlook
The market is segmented based on type, treatment, and end-user. By type, the market is segmented into non-segmental vitiligo and segmental vitiligo. Further, based on the treatment segment, the market is segmented into therapy, surgery, and medication. Based on the end-user segment, the market is divided into hospitals and aesthetic clinics.
By Type (Non-Segmental Vitiligo, and Segmental Vitiligo),
By Treatment (Therapy, Surgery, and Medication), and
By End-User (Hospitals, and Aesthetic Clinics)
Market Players Outlook
The prominent players functioning in the global vitiligo treatment market include AVITA Medical, Incyte Corp., TWi Biotechnology, Dermavant Sciences, Inc., and Clinuvel Pharmaceuticals Ltd. among others. These key manufacturers are adopting various strategies such as new product launches and approvals, mergers and acquisitions, partnerships, and collaborations, and many others to thrive in a competitive environment. For instance, in December 2021, FDA had agreed to Phase II study CUV104 that would be evaluating CLINUVEL’s drug SCENESSE which is considered as a monotherapy in patients with the depigmentation disorder vitiligo. Additionally, Clinuvel Pharmaceuticals Ltd. had reached an agreement on the clinical protocol and will commence the CUV104 study at a specialist hospital department in the US.
In October 2020, Avita Medical which is considered as one of the regenerative medicine companies, which had launched a clinical study in order to evaluate for the purpose of analyzing the safety and effectiveness of its RECELL System in the effective treatment of vitiligo. The RECELL System is considered as a system utilizing a small amount of a patient’s healthy skin to prepare a suspension of Spray-On Skin Cells, which is then applied to the vitiligo.
In December 2019, Dermavant Sciences Inc. had set forth the information for its dose of Phase 2a vitiligo clinical trial for topical cerdulatinib. The Cerdulatinib is considered as a dual inhibitor of the Janus kinase (JAK) and spleen tyrosine kinase (Syk) pathways, which the company is evaluating as a differentiated topical treatment option for vitiligo.
The Report Covers
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global vitiligo treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market entry and market expansion strategies.
Competitive strategies by identifying ‘who-stands-where’ in the market.
Inquire for Discount on this Report at
https://www.omrglobal.com/report-customization/vitiligo-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404